UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination

British journal of clinical pharmacology, 2023-03, Vol.89 (3), p.967-981

2023

Volltextzugriff (PDF)

Cholecystitis and cholangitis associated with lenvatinib: A pharmacovigilance study

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.579-581

2023

Volltextzugriff (PDF)

Pharmacovigilance in China: Evolution and future challenges

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.510-522

2023

Volltextzugriff (PDF)

Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections

British journal of clinical pharmacology, 2021-11, Vol.87 (11), p.4421-4431

2021

Volltextzugriff (PDF)

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns

Clinical microbiology and infection, 2021-05, Vol.27 (5), p.791.e5-791.e8

2021

Volltextzugriff (PDF)

The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database

British journal of clinical pharmacology, 2017-06, Vol.83 (6), p.1341-1349

2017

Volltextzugriff (PDF)

Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database

British journal of clinical pharmacology, 2021-11, Vol.87 (11), p.4334-4340

2021

Volltextzugriff (PDF)

Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.431-439

2023

Volltextzugriff (PDF)

Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.865-873

2023

Volltextzugriff (PDF)

Drug‐induced peripheral oedema: An aetiology‐based review

British journal of clinical pharmacology, 2021-08, Vol.87 (8), p.3043-3055

2021

Volltextzugriff (PDF)

Thirst and drugs: A study in the World Health Organization's pharmacovigilance database

British journal of clinical pharmacology, 2024-06, Vol.90 (6), p.1525-1528

Montastruc, Jean‐Louis

2024

Volltextzugriff (PDF)

Development and validation of a predictive tool for adverse drug reactions in neonates under intensive care

British journal of clinical pharmacology, 2024-03, Vol.90 (3), p.793-800

2024

Volltextzugriff (PDF)

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

The European respiratory journal, 2019-12, Vol.54 (6), p.1901522

2019

Volltextzugriff (PDF)

PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study)

British journal of clinical pharmacology, 2024-04, Vol.90 (4), p.1050-1057

2024

Volltextzugriff (PDF)

Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.551-555

2023

Volltextzugriff (PDF)

Updated insights on dementia‐related risk of sacubitril/valsartan: A real‐world pharmacovigilance analysis

CNS neuroscience & therapeutics, 2023-09, Vol.29 (9), p.2548-2554

2023

Volltextzugriff (PDF)

Considerations on the use of different comparators in pharmacovigilance: A methodological review

British journal of clinical pharmacology, 2023-09, Vol.89 (9), p.2671-2676

2023

Volltextzugriff (PDF)

Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database

Allergy (Copenhagen), 2021-10, Vol.76 (10), p.3209-3211

2021

Volltextzugriff (PDF)

Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta‐analysis

European journal of heart failure, 2021-10, Vol.23 (10), p.1739-1747

2021

Volltextzugriff (PDF)

Quo vadis (where are you going) pharmacovigilance?

British journal of clinical pharmacology, 2023-02, Vol.89 (2), p.428-430

2023

Volltextzugriff (PDF)

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

Arthritis & rheumatology (Hoboken, N.J.), 2018-09, Vol.70 (9), p.1399-1407

2018

Volltextzugriff (PDF)

Lessons learned on the design and the conduct of Post‐Authorization Safety Studies: review of 3 years of PRAC oversight

British journal of clinical pharmacology, 2017-04, Vol.83 (4), p.884-893

2017

Volltextzugriff (PDF)

E‐pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions

British journal of clinical pharmacology, 2013-09, Vol.76 (S1), p.69-77

2013

Volltextzugriff (PDF)

Innovations in pharmacovigilance studies of medicines in older people

British journal of clinical pharmacology, 2024-03

2024

Volltextzugriff (PDF)

Regulatory challenges with biosimilars: an update from 20 countries

Annals of the New York Academy of Sciences, 2021-05, Vol.1491 (1), p.42-59

2021

Volltextzugriff (PDF)

1 – 25 von 527

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

KollektionWiley Online Library All Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(526)
Mit Volltextzugriff
(525)

Publikationsform

Artikel
(527)

Sprache

Englisch
(527)

Erscheinungsjahr

n.n

Thema

Pharmacovigilance
(515)
Science & Technology
(484)
Life Sciences & Biomedicine
(481)
Humans
(366)
Pharmacology & Pharmacy
(297)
Female
(150)
Male
(123)
Aged
(101)
Adult
(97)
Middle Aged
(95)
Patients
(77)
Drug Safety
(76)
Original
(68)
Adverse Drug Reaction Reporting Systems
(66)
Biological And Medical Sciences
(62)
Medical Sciences
(62)
Adverse Drug Reactions
(61)
Drugs
(60)
Pharmacology. Drug Treatments
(56)
Clinical Trials
(54)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination

Cholecystitis and cholangitis associated with lenvatinib: A pharmacovigilance study

Pharmacovigilance in China: Evolution and future challenges

Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns

The drugs that mostly frequently induce acute kidney injury: a case − noncase study of a pharmacovigilance database

Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database

Active‐comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors

Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database

Drug‐induced peripheral oedema: An aetiology‐based review

Thirst and drugs: A study in the World Health Organization's pharmacovigilance database

Development and validation of a predictive tool for adverse drug reactions in neonates under intensive care

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

PAttern of drug use in PEdiatrics: An observational study in Italian hOSpitals (the PAPEOS study)

Acute appendicitis in a patient immunised with COVID‐19 vaccine: A case report with morphological analysis

Updated insights on dementia‐related risk of sacubitril/valsartan: A real‐world pharmacovigilance analysis

Considerations on the use of different comparators in pharmacovigilance: A methodological review

Potential cancer risk with omalizumab? A disproportionality analysis of the WHO's VigiBase pharmacovigilance database

Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta‐analysis

Quo vadis (where are you going) pharmacovigilance?

Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database

Lessons learned on the design and the conduct of Post‐Authorization Safety Studies: review of 3 years of PRAC oversight

E‐pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions

Innovations in pharmacovigilance studies of medicines in older people

Regulatory challenges with biosimilars: an update from 20 countries

Aktive Filter

Suchergebnisse filtern